Hercules Capital Announces Fourth Quarter and Full-Year 2017 Financial Results and Quarterly Distribution of $0.31 per Share

PALO ALTO, Calif.–(BUSINESS WIRE)–Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, today announced its financial results for the fourth quarter and fiscal-year ended December 31, 2017. The Company announced that its Board of Directors has declared a fourth quarter cash distribution of $0.31 per share, that will be payable on March 12, 2018, to shareh

HydroPICC Anti-thrombogenic Central Line Catheter Cleared by FDA

Access Vascular, a company based in Bedford, MA that makes a novel material for preventing the clogging up of catheters, won FDA clearance for its HydroPICC catheter. The company’s “bulk-hydrophilic” material is rich in water and carries a neutral surface charge, which helps to prevent proteins and other biomaterials from sticking (Read more...)

Global Uveitis Market Report 2018: Insights, Epidemiology and Market Forecasts to 2027 – Vimpat was the Best Selling Drug in 2016 Followed by Lamictal and Keppra – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Uveitis – Market Insights, Epidemiology and Market Forecasts to 2027” drug pipelines has been added to ResearchAndMarkets.com’s offering. Uveitis market is expected to grow during the forecasted period of 2018-2027 owing t…